A comparison of ThinPrep against four non-volatile transport media for HPV testing at or near the point of care.


Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 18 06 2020
revised: 26 10 2020
accepted: 29 10 2020
pubmed: 29 12 2020
medline: 25 2 2023
entrez: 28 12 2020
Statut: ppublish

Résumé

The Xpert HPV Test is used at point of care for cervical screening in a number of low and middle income countries (LMIC). It is validated for use with ThinPrep-PreservCyt transport medium which has a high methanol content and is therefore classified as a dangerous good for shipping, making cost, transportation and use challenging within LMIC. We compared the performance of ThinPrep against four non-volatile commercially available media for human papillomavirus (HPV) point of care testing. Ten-fold serial dilutions were prepared using three HPV cell lines each positive for 16, 18 or 31 and with each suspended in five different media types. The media types consisted of Phosphate Buffered Saline (ThermoFisher Scientific, USA), Sigma Virocult (Medical Wire and Equipment, UK), MSwab (Copan, Italy) Xpert Transport Media (Cepheid, USA) and ThinPrep-PreservCyt (Hologic, USA). A total of 105 Xpert HPV tests were conducted in a laboratory setting, with seven 10-fold dilutions of each of the three HPV genotypes tested in all five media types. The lowest HPV 10-fold dilution detected for any media, or cell line was the fifth dilution. MSwab was the only medium to detect HPV to the fifth dilution across all three cell types. MSwab transport media may be a suitable alternative to ThinPrep for Xpert HPV point of care testing. A field based, head to head comparison of both media types using the Xpert HPV assay is warranted to confirm these laboratory based findings.

Identifiants

pubmed: 33358758
pii: S0031-3025(20)31005-9
doi: 10.1016/j.pathol.2020.10.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

264-266

Informations de copyright

Copyright © 2020 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Auteurs

S G Badman (SG)

Kirby Institute, UNSW Sydney, NSW, Australia. Electronic address: sbadman@kirby.unsw.edu.au.

A J Vallely (AJ)

Kirby Institute, UNSW Sydney, NSW, Australia; Sexual and Reproductive Health Unit, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

C Pardo (C)

Centre for Clinical Research, The University of Queensland, Brisbane, Qld, Australia.

L P Mhango (LP)

Centre for Clinical Research, The University of Queensland, Brisbane, Qld, Australia.

A M Cornall (AM)

Centre for Women's Infectious Diseases, Royal Women's Hospital, Melbourne, Vic, Australia; Molecular Microbiology Research Group, Murdoch Children's Research Institute, Melbourne, Vic, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Vic, Australia.

J K Kaldor (JK)

Kirby Institute, UNSW Sydney, NSW, Australia.

D Whiley (D)

Centre for Clinical Research, The University of Queensland, Brisbane, Qld, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH